This is a registry record, not a result. A trial being listed, recruiting or completed says nothing by itself about whether the compound works or is safe.
| Registry number | NCT00394667 |
|---|---|
| Status | Completed |
| Phase | Phase 2 |
| Sponsor | NeuroSearch A/S |
| Enrollment | 200 participants |
| Design | Interventional, Randomized, Parallel, Masking: Double |
| Conditions | Obesity |
| Interventions | Tesofensine |
| Start | Sep 2006 |
| Primary completion | Not stated |
| Study completion | Sep 2007 |
| Results posted | Not yet |
| Registry last updated | Apr 22, 2013 |
Compounds on this site that cite this trial
What the registry says the trial is about
Purpose:
To evaluate the efficacy on weight reduction, metabolic parameters and safety of tesofensine versus placebo in obese patients
Primary outcomes
These are what the trial was designed to measure first. They are registered in advance, which is what makes a later result checkable.
| Outcome measure | Time frame |
|---|---|
| Percent change and absolute change in body weight |
4 secondary outcomes also registered. See the registry record for the full list.
Source: ClinicalTrials.gov (U.S. National Library of Medicine). Last checked against the registry on Oct 3, 2026. See the trial changes feed for what has changed recently.
